Larynx transplantation: Laryngectomees' opinion poll

Transplantation

Volumn 84, Issue 12, 2007, Pages 1584-1589

  Buiret, Guillaume ^a,f   Rabilloud, Muriel ^b   Combe, Claire ^c   Paliot, Hugues ^d   Disant, François ^e   Céruse, Philippe ^a  

^a Hospices Civil de Lyon   (France)

^b Lacassagne Regional and Universitary Hospital   (France)

^c Groupe PPEH   (France)

^d Centre hospitalier Saint Luc et Saint Joseph   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f NONE   (France)

Author keywords

Laryngectomy; Larynx transplantation; Opinion poll

Indexed keywords

ARTICLE; DEMOGRAPHY; FOLLOW UP; FRANCE; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; LARYNGECTOMY; LARYNX INJURY; LARYNX TRANSPLANTATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; TRANSPLANTATION; TREATMENT REFUSAL;

AGED; FEMALE; HUMANS; LARYNGECTOMY; LARYNX; MALE; MARITAL STATUS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SPEECH, ESOPHAGEAL;

EID: 37549017749     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000295716.21536.76     Document Type: Article

References (12)

1. Remontet L, Buemi A, Velten M, et al. Evolution de l'incidence et de la mortalité par cancer en France de 1978 á 2000. INVS 2003; 1-217.
2. Strome M, Stein J. Laryngeal transplantation and 40 months follow-up. N Engl J Med 2001; 344: 1676.
3. Potter CP, Birshall MA. Laryngectomees' point of view on laryngeal transplantation. Transplant Int 1998; 11: 433.
4. Armstorng E, Isman K, Dooley P, et al. An investigation into quality of life of individuals after laryngectomy. Head Neck 2001; 23: 16.
5. Vilaseca I, Chen AY, Backscheider AG. Long-term quality of life after total laryngectomy. Head Neck 2006; 28: 313.
6. Lin K, Patel SG, Chu PY, et al. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005; 27: 1042.
7. Schwarz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 1933.
8. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporine regimens. Lancet 1998; 351: 623.
9. Kaufman MH, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycine inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80: 883.
10. Fingar DF, Blenis J. Target of rapamycin: An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23: 3151.
11. Koehl GE, Andrassy J, Guba M, et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 2004; 77: 1319.
12. Kaufman MH, Cherikh WS, McBride MA, et al. Post-transplant malignancies in renal transplant recipients: the past and present. Transplant Int 2006; 19: 607.